Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

for
Primary Central Nervous System Lymphoma,
Location: Boston MA
Sponsor: Lakshmi Nayak, MD

Sex: All

Age: 18+

Code: NCT04906096

Phase2, Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

for
B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05432635

Phase1, Recruiting

A Registry for People With T-cell Lymphoma

for
T-cell Lymphoma, NK-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT05978141

Recruiting

Emapalumab Prevention of CAR-T Cell Associated Toxicities

for
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma,
Location: Boston MA
Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All

Age: 18+

Code: NCT06550141

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03516617

Phase2, Recruiting

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Kerry Rogers

Sex: All

Age: 18+

Code: NCT06466122

Phase2, Recruiting

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

for
Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL),
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT04186520

Phase1, Phase2, Recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

for
Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma,
Location: Indianapolis IN
Sponsor: Rita Assi

Sex: All

Age: 18+

Code: NCT06484920

Phase2, Recruiting

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04941716

Phase2, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Boston MA, Quebec, New York NY, Bethesda MD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase1, Phase2, Recruiting

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

for
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05389423

Phase1, Recruiting

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

for
Diffuse Large B Cell Lymphoma, Lymphoma, Non-Hodgkin
Location: Baltimore MD, Randallstown MD
Sponsor: The Alvin and Lois Lapidus Cancer Institute

Sex: All

Age: 18+

Code: NCT00333008

Phase2, Recruiting

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06364423

Phase1, Phase2, Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

for
Clonal Cytopenia of Undetermined Significance,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03418038

Phase2, Recruiting

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

for
Recurrent Acute Lymphoblastic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 15+

Code: NCT03136146

Phase2, Recruiting

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Location: Newnan GA, Zion IL, Goodyear AZ, Duarte CA
Sponsor: VIVUS LLC

Sex: All

Age: 18+

Code: NCT06915246

Phase2, Recruiting

Photopheresis in Early-stage Mycosis Fungoides

for
Cutaneous T Cell Lymphoma, Mycosis Fungoides
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT05680558

Phase2, Recruiting

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

for
Advanced Solid Tumor, Refractory Hodgkin Lymphoma
Location: Greenville SC
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT06487624

Phase1, Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

for
B-ALL, DLBCL, B ALL, Dlbcl-Ci, DLBCL Unclassifiable,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04512716

Early_phase1, Recruiting